Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  The Pediatric clinics of North America

• Publication date

  2012-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.pcl.2012.03.002PMID 22560573PMCID PMC3368378
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical significance of hemophagocytosis in BM clot sections during the peri-engraftment period following allogeneic hematopoietic SCT

  2012cited by this paper
• Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids.

  2011cited by this paper
• Perforin is a critical physiologic regulator of T-cell activation.

  2011cited by this paper
• Genetic and Molecular Basis of Inflammasome-mediated Disease*

  2011cited by this paper
• Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis.

  2011cited by this paper
• Hemophagocytosis causes a consumptive anemia of inflammation

  2011cited by this paper
• Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).

  2011cited by this paper
• Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice.

  2011cited by this paper
• Serum Neopterin Levels as a Diagnostic Marker of Hemophagocytic Lymphohistiocytosis Syndrome

  2011cited by this paper
• Reduced‐intensity conditioning haematopoietic cell transplantation for haemophagocytic lymphohistiocytosis: an important step forward

  2011cited by this paper
• An International Consensus Survey of Diagnostic Criteria for Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis

  2011cited by this paper
• Association of IRF5 Polymorphisms with Susceptibility to Macrophage Activation Syndrome in Patients with Juvenile Idiopathic Arthritis

  2011cited by this paper
• Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice.

  2011cited by this paper
• Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.

  2011cited by this paper
• Sustained IL-4 exposure leads to a novel pathway for hemophagocytosis, inflammation, and tissue macrophage accumulation.

  2010cited by this paper
• IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA).

  2010cited by this paper
• Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis.

  2010cited by this paper
• Chronic Murine Typhoid Fever Is a Natural Model of Secondary Hemophagocytic Lymphohistiocytosis

  2010cited by this paper
• Cytokine Profiles of Macrophage Activation Syndrome Associated with Rheumatic Diseases

  2010cited by this paper
• Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis.

  2010cited by this paper
• Inherited defects in lymphocyte cytotoxic activity

  2010cited by this paper
• correspondence: A novel assay for investigation of suspected familial haemophagocytic lymphohistiocytosis

  2010cited by this paper
• Haemophagocytic syndrome and HIV

  2009cited by this paper
• Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.

  2009influential reference
• Emerging roles of TLR7 and TLR9 in murine SLE.

  2009cited by this paper
• Experience With Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome at a Single Institution

  2009influential reference
• Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis

  2008cited by this paper
• TLR9 Contributes to Antiviral Immunity during Gammaherpesvirus Infection1

  2008influential reference
• Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms.

  2008cited by this paper
• Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders

  2008cited by this paper
• Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome.

  2007influential reference
• The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.

  2007cited by this paper
• Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis.

  2007cited by this paper
• TLR7/9 antagonists as therapeutics for immune-mediated inflammatory disorders.

  2007cited by this paper
• Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.

  2007cited by this paper
• Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis

  2007cited by this paper
• HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis

  2007influential reference
• Interleukin 1 receptor antagonist to treat cytophagic histiocytic panniculitis with secondary hemophagocytic lymphohistiocytosis.

  2006cited by this paper
• Toll-like receptors in systemic autoimmune disease

  2006cited by this paper
• PERIPHERAL HEMOPHAGOCYTOSIS: AN EARLY INDICATOR OF ADVANCED SYSTEMIC INFLAMMATORY RESPONSE SYNDROME/HEMOPHAGOCYTIC SYNDROME

  2006cited by this paper
• Novel IL10 gene family associations with systemic juvenile idiopathic arthritis

  2006cited by this paper
• Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood.

  2006cited by this paper
• Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

  2005cited by this paper
• Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

  2005cited by this paper
• International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics*

  2005cited by this paper
• An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.

  2004cited by this paper
• Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome

  2004influential reference
• Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome.

  2003influential reference
• Alternative activation of macrophages

  2003cited by this paper
• Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation.

  2002cited by this paper
• Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

  2002cited by this paper
• Secondary hemophagocytic lymphohistiocytosis in children: an analysis of etiology and outcome.

  2002cited by this paper
• Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders

  2001cited by this paper
• Interleukin-10 and the interleukin-10 receptor.

  2001cited by this paper
• Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis.

  1998influential reference
• American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

  1992cited by this paper
• Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

  1992cited by this paper

• Coagulation dysfunction in children with secondary hemophagocytic lymphohistiocytosis: a comprehensive analysis

  2026cites this paper
• The ZFP36-FTO axis is a key regulator of macrophage activation and a druggable therapeutic target of sepsis

  2025cites this paper
• Prediction nomogram of serum interferon-γ enable early identification of macrophage activation syndrome in children with Kawasaki disease

  2025cites this paper
• Chronic Inflammatory-Related Disease and Cardiovascular Disease in MESA

  2025cites this paper
• The HScore to Diagnose HLH in Scrub Typhus: Overdiagnosis or under Diagnosis and Does It Really Matter?

  2024cites this paper
• Genetics of Acquired Cytokine Storm Syndromes : Secondary HLH Genetics.

  2024cites this paper
• The therapeutic potential of gelsolin in attenuating cytokine storm, ARDS, and ALI in severe COVID-19

  2024cites this paper
• An antibody to IL-1 receptor 7 protects mice from LPS-induced tissue and systemic inflammation

  2024cites this paper
• New discoveries in the genetics and genomics of systemic juvenile idiopathic arthritis

  2024cites this paper
• Causes of hyperferritinemia: what has changed with the pandemic?

  2024cites this paper
• Salvage Therapy and Allogeneic Hematopoietic Cell Transplantation for the Severe Cytokine Storm Syndrome of Hemophagocytic Lymphohistiocytosis.

  2024cites this paper
• The Protective Role of Transcription Factor Nrf2 in Murine Macrophage Activation Syndrome.

  2024cites this paper
• Into the storm: the imbalance in the yin-yang immune response as the commonality of cytokine storm syndromes

  2024cites this paper
• Emapalumab Treatment in Patients With Rheumatologic Disease–Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study

  2024cites this paper
• DEPENDENT PATHWAY IN MYELOID CELLS MODULATES THE PATHOGENESIS OFCYTOKINE STORM SYNDROME

  2023cites this paper
• CXCL9 inhibition does not ameliorate disease in murine models of both primary and secondary hemophagocytic lymphohistiocytosis

  2023cites this paper
• Secondary hemophagocytic lymphohistiocytosis in children (Review)

  2023cites this paper
• Carbamazepine‐induced liver injury in an 11‐year‐old female: Case report and review of the literature

  2022cites this paper
• Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza

  2022cites this paper
• Familial hemophagocytic lymphohistiocytosis hepatitis is mediated by IFN-γ in a predominantly hepatic-intrinsic manner

  2022cites this paper
• Acute Ischemic Stroke in Relation of COVID-19

  2022cites this paper
• Drugs for paediatric hyperinflammatory syndromes

  2022cites this paper
• The mechanistic basis linking cytokine storm to thrombosis in COVID-19

  2022cites this paper
• Infection-Triggered Hyperinflammatory Syndromes in Children

  2022cites this paper
• Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells

  2021cites this paper
• What Is a Cytokine Storm and Should It Matter to Me?

  2021cites this paper
• Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still’s Disease: Similarities and Differences

  2021cites this paper
• Genotoxicity and Immunotoxicity of Titanium Dioxide-Embedded Mesoporous Silica Nanoparticles (TiO2@MSN) in Primary Peripheral Human Blood Mononuclear Cells (PBMC)

  2021cites this paper
• Immune cartography of macrophage activation syndrome in the COVID-19 era

  2021cites this paper
• The Novel Coronavirus and Inflammation.

  2021cites this paper
• Bispecific antibody therapy, its use and risks for infection: Bridging the knowledge gap.

  2021cites this paper
• Prognostic Values of Serum Ferritin and D-Dimer Trajectory in Patients with COVID-19

  2021cites this paper
• A novel anti-human IL-1R7 antibody reduces IL-18-mediated inflammatory signaling

  2021cites this paper
• Metabolic alterations in the critically ill child

  2021cites this paper
• Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications

  2021cites this paper
• Cytokine Storm Syndrome, a potential cause of death in COVID-19 patients

  2021cites this paper
• Cytokine Profile in Children with Severe Multisystem Inflammatory Syndrome Related to the Coronavirus Disease 2019

  2021cites this paper
• Potential Immunological Treatments in COVID-19 Patients

  2021influential citation
• Sea Urchin Pigments: Echinochrome A and Its Potential Implication in the Cytokine Storm Syndrome

  2021cites this paper
• The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile

  2021cites this paper
• Macrophage Activation Syndrome in Adults: A Retrospective Case Series

  2021cites this paper
• Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID‐19 pneumonia

  2021cites this paper
• Hide and seek in a pandemic: review of SARS‐CoV‐2 infection and sequelae in children

  2021cites this paper
• Macrophage activation syndrome: A diagnostic challenge (Review)

  2021cites this paper
• ИНТЕНСИВНАЯ ТЕРАПИЯ НОВОЙ КОРОНАВИРУСНОЙ ИНФЕКЦИИ COVID-19 INTENSIVE CARE FOR THE NOVEL CORONAVIRUS INFECTION

  2021cites this paper
• 50 Years of Sepsis Investigation/Enlightenment Among Adults-The Long and Winding Road.

  2021cites this paper
• The role of infective trigger for macrophage activation syndrome in rheumatic diseases. A retrospective analysis in a tertiary pediatric care centre and review of the literature

  2021cites this paper
• Managing the Cytokine Storm in COVID-19: Can Melatonin Play a Part?

  2021cites this paper
• Vitamin D is a strategic blow to coronavirus infection

  2021cites this paper
• [Hemophagocytic syndrome at a pediatric specialty hospital. Underdiagnosis and overdiagnosis].

  2021cites this paper
• What was said about COVID-19 and what we heard and what we saw!

  2021cites this paper
• Vitamin D and its' role in Parkinson's disease patients with SARS-CoV-2 infection. A review article

  2021cites this paper
• Antiviral and anti-inflammatory drugs to combat COVID-19: Effects on cardiac ion channels and risk of ventricular arrhythmias

  2021cites this paper
• The Potential Impact of Statins in the Treatment of Patients with COVID-19 Infection.

  2021cites this paper
• имму-Critical appraisal of the “cytokine storm” concept in new coronavirus disease COVID-19. Review

  2021cites this paper
• N6-Adenosine Methylation of Socs1 mRNA Is Required to Sustain the Negative Feedback Control of Macrophage Activation.

  2020cites this paper
• Influenza infection, SARS, MERS and COVID-19: Cytokine storm – The common denominator and the lessons to be learned

  2020cites this paper
• Preparing for the Storm: Mitigating the Effect of SARS-CoV-2 Induced Hypercytokinemia

  2020cites this paper
• T cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis.

  2020cites this paper
• Artificial Neural Networks for Modeling the Interaction between Cytokines Inducing Lymphopenia in Patients with COVID-19

  2020cites this paper
• Pediatric hemophagocytic lymphohistiocytosis: A rarely diagnosed entity in a developing country

  2020cites this paper
• Clinical variability of the systemic juvenile idiopathic arthritis course: literature review based on case series

  2020cites this paper
• Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis

  2020cites this paper
• The genetics of macrophage activation syndrome

  2020cites this paper
• Treatment of Covid-19 Infection. A Rationale for Current andFuture Pharmacological Approach

  2020influential citation
• Cytokine storm syndrome in severe COVID-19

  2020cites this paper
• COVID-19: Cytokine Storm - The Egyptian Integrated Medicine

  2020cites this paper
• Potential Role of Vitamin D in the Elderly to Resist COVID-19 and to Slow Progression of Parkinson’s Disease

  2020influential citation
• Be alert for macrophage activation syndrome in seriously sick children with underlying pro-inflammatory disorders

  2020cites this paper
• Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence

  2020cites this paper
• Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm

  2020cites this paper
• A novel Cre-enabled tetracycline-inducible transgenic system for tissue-specific cytokine expression in the zebrafish: CETI-PIC3

  2020cites this paper
• Diacerein: A potential multi-target therapeutic drug for COVID-19

  2020influential citation
• Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19

  2020cites this paper
• JAK/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation.

  2020cites this paper
• Be alert for macrophage activation syndrome in seriously sick children with underlying pro-inflammatory disorders

  2020cites this paper
• SARS-CoV-2 and cancer: Are they really partners in crime?

  2020cites this paper
• The Cytokine Storm and Pre-Cytokine Storm Status in COVID-19-A Model for Managing Population Risk for Pandemics and Chronic Diseases

  2020cites this paper
• Challenges in the development of nanoparticle-based imaging agents: Characterization and biology.

  2020cites this paper
• Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses

  2020cites this paper
• nCOVID-19: Its diagnosis, possible preventive measures, therapeutic interventions and management

  2020cites this paper
• Exercise for Older Adults Improves the Quality of Life in Parkinson’s Disease and Potentially Enhances the Immune Response to COVID-19

  2020cites this paper
• “Cytokine storm”, not only in COVID-19 patients. Mini-review

  2020influential citation
• miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis.

  2020cites this paper
• Inflammation Unrestrained by SIRPα Induces Secondary Hemophagocytic Lymphohistiocytosis Independent of IFN-γ

  2020cites this paper
• The Comprehensive Appraisal of COVID-19: Its’ Clinical Panorama from Virology till Management and Beyond

  2020cites this paper
• Cytokine storm is the cryptic killer behind coronavirus disease-2019 infections, review of the current evidence to identify therapeutic options

  2020cites this paper
• The Potential Detrimental Role of High Salt Diet in Promoting Exaggerated Th-17 Responses in COVID-19 Patients, an Intriguing Hypothesis

  2020cites this paper
• Linfohistiocitosis hemofagocítica en trasplante renal

  2019cites this paper
• Genetics of Acquired Cytokine Storm Syndromes

  2019cites this paper
• Clinical characteristics of liver failure with hemophagocytic lymphohistiocytosis

  2019cites this paper
• Hämophagozytische Lymphohistiozytose – eine seltene, aber schwere Komplikation

  2019cites this paper
• Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway

  2019cites this paper
• Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management

  2019cites this paper
• Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg.

  2019cites this paper
• Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatment.

  2019cites this paper
• Development of Organic Carbon Monoxide prodrugs

  2019cites this paper
• Mechanisms of Action of Ruxolitinib in Murine Models of Hemophagocytic Lymphohistiocytosis.

  2019cites this paper
• Toll-Like Receptor-Mediated Recognition of Nucleic Acid Nanoparticles (NANPs) in Human Primary Blood Cells

  2019cites this paper
• Effect of Serum Deprivation Stress on Signal Induction Regulatory Protein-Alpha (SIRP-Alpha)-Mediated Erythrophagocytosis by Macrophages

  2019influential citation